Rafferty Asset Management, LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 1389426 New York, NY

Position in ABUS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$490,416

-$62,427 QoQ

Shares Held

102,170

-16.8% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 175 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. ABUS ranks #119 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$490,416	102,170	-16.8%	Shares	Sole	2026-08-14
2026-03-31	$552,843	122,854	+5.0%	Shares	Sole	2026-05-15
2025-12-31	$562,923	117,032	+120.8%	Shares	Sole	2026-02-13
2025-09-30	$240,656	53,008	-40.1%	Shares	Sole	2025-11-12
2025-06-30	$273,322	88,454	+6.7%	Shares	Sole	2025-08-14
2025-03-31	$289,195	82,864	-43.6%	Shares	Sole	2025-05-14
2024-12-31	$480,045	146,803	+27.6%	Shares	Sole	2025-02-14
2024-09-30	$442,830	115,021	+262.9%	Shares	Sole	2024-11-13
2023-03-31	$96,029	31,693	-66.5%	Shares	Sole	2023-05-11
2022-12-31	$220,196	94,505	+73.9%	Shares	Sole	2023-02-13
2022-09-30	$103,768	54,329	-19.8%	Shares	Sole	2022-11-14
2022-06-30	$183,564	67,736	+12.1%	Shares	Sole	2022-08-12
2022-03-31	$179,994	60,401	+146.3%	Shares	Sole	2022-05-13
2021-12-31	$95,390	24,522	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.